0001493152-22-010294.txt : 20220419
0001493152-22-010294.hdr.sgml : 20220419
20220419080522
ACCESSION NUMBER: 0001493152-22-010294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220418
FILED AS OF DATE: 20220419
DATE AS OF CHANGE: 20220419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILBY RANDY
CENTRAL INDEX KEY: 0001360968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41210
FILM NUMBER: 22833504
MAIL ADDRESS:
STREET 1: 5 JACK LANE
CITY: NEWARK
STATE: DE
ZIP: 19711
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hillstream BioPharma Inc.
CENTRAL INDEX KEY: 0001861657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 842642541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 ROUTE 22 EAST
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 302-743-2995
MAIL ADDRESS:
STREET 1: 245 MAIN STREET
STREET 2: SUITE 204
CITY: CHESTER
STATE: NJ
ZIP: 07930
4
1
ownership.xml
X0306
4
2022-04-18
0
0001861657
Hillstream BioPharma Inc.
HILS
0001360968
MILBY RANDY
C/O HILLSTREAM BIOPHARMA, INC.
1200 ROUTE 22 EAST, SUITE 2000
BRIDGEWATER
NJ
08807
1
1
0
0
Chief Executive Officer
Common Stock
2022-04-18
4
X
0
7575
0.314
A
2701588
D
Common Stock
2022-04-18
4
X
0
7575
0.314
A
2709163
D
Common Stock
2022-04-18
4
X
0
189393
0.079
A
2898556
D
Common Stock
2022-04-18
4
X
0
28408
0.079
A
2926964
D
Common Stock
2022-04-18
4
X
0
7575
0.314
A
2934539
D
Options (right to purchase)
0.314
2022-04-18
4
X
0
7575
0
D
2020-02-29
2030-02-28
Common stock
7575
0
D
Options (right to purchase)
0.314
2022-04-18
4
X
0
7575
0
D
2020-01-31
2030-01-31
Common stock
7575
0
D
Options (right to purchase)
0.079
2022-04-18
4
X
0
189393
0
D
2024-08-30
Common stock
189393
0
D
Options (right to purchase)
0.079
2022-04-18
4
X
0
28408
0
D
2024-07-31
Common stock
28408
9470
D
Options (right to purchase)
0.314
2022-04-18
4
X
0
7575
0
D
2020-03-31
2030-03-31
Common stock
7575
0
D
The Registrant issued the Reporting Person the options on August 30, 2019. The options vested on the date of grant and became exercisable upon completion of the Registrant's initial public offering.
The Registrant issued the Reporting Person the options on July 31, 2019. The options vest as follows: (i) 9,469 options vested and became exercisable on July 31, 2020 and (ii) the balance of the options shall vest and become exercisable in 48 equal monthly installments such that the options shall vest in full by the 4th anniversary of the initial issuance date.
/s/ Randy Milby
2022-04-19